New cancer clinical trial: A Pilot Study of Combination Immunotherapy With Ipilimumab and Nivolumab in Patients With Recurrent Extensive Stage Small Cell Lung Cancer (SCLC) Who Have Previously Received Platinum-based Chemotherapy

Published on: September 13, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share